Page 12 - Pharma Stocks

Jhunjhunwala Portfolio: This pharma stock has zoomed over 100% in 6 months

Shares of Jubilant Pharmova surged 12 per cent on the BSE in Friday's intra-day trade to hit a new high of Rs 1,169.55, in an otherwise subdued market.

Panacea Biotec gets $20 mn loan from US DFC for capex; stock rises 5%

The shares of Panacea Biotec rose after the company announced that it has secured $20 million in loan from US International Development Finance Corp (DFC).

Granules tanks 16% on concerns over 6 observations issued by US FDA

More than 31 million equity shares, representing 12.89 per cent equity of the pharmaceutical company, had changed hands on the NSE till 02:08 PM.

EU GMP Certification sends this small-cap pharma stock flying over 14%

Shares of pharmaceutical company, Medicamen Biotech have advanced 16.15 per cent in the last one week, and 20 per cent in the last one month

This SME stock has surged 61% in 12 days; zoomed 328% in 3 months

Shares of Sudarshan Pharma Industries were frozen in upper circuit of 5 per cent at Rs 274.50, which is also the new high it hit on the BSE in Thursday's intra-day trade.

Pharma stocks soar 6% as investors respond to double dose of Good News!

Individually, shares of Laurus Labs rose up to 5.55 per cent at Rs 517.90 per share, Akums Drugs and Pharmaceuticals shares locked in 5 per cent upper circuit at Rs 910.55 a piece

Panacea Biotec freezes in 10% upper circuit; stock zooms 101% in 1 month

A combined 2.1 million equity shares of the company had changed hands till 02:50 PM, and there are pending buy orders for nearly 100,000 shares on the NSE and BSE.

Concord Biotech shares hit all time high; Antique Broking reiterates 'Buy'

Antique Broking is bullish on Concord's business model, new launches and niche products

Natco Pharma rises 4% after filing ANDA for generic lung cancer drug

Natco Pharma is the first company to have filed a substantially complete ANDA for a generic cancer drug

USFDA approval sends this multibagger pharma stock to 52-week high

Northward surge in the stock price is attributed to the news that the company has received approval from the US Food and Drug Administration (USFDA) for its product, 'Bortezomib Injection NDA 212782

Wanbury jumps 4% after firm gets zero form 483 observations from USFDA

Shares of pharma company Wanbury climbed nearly 4 per cent on Friday after the company received an EIR with zero form 483 observations, from the USFDA

Aarti Drugs surges 13% as board mulls share buyback on August 26

Going ahead in FY25, the management anticipates an improvement in margins, mostly driven by an anticipated growth in export sales and backward integration.

Pfizer surges 3% as investors cheer 350% dividend announcement; details

The northward movement in the rally follows the announcement of a whopping 350 per cent dividend, or Rs 35 per share, for FY24

Here's why Glenmark Pharma stock hit all time high on Aug 19; details here

The rise in the share price came after the company announced that its unit, Glenmark Therapeutics Inc, USA (Glenmark) has launched Olopatadine Hydrochloride Ophthalmic Solution USP, 0.1 per cent.

Aurobindo Pharma stock tanks 6% after unit gets warning letter from USFDA

The drop in the share price came after the company announced that its' arm Eugia Pharma Specialties' Unit-III received a warning letter from United States Food and Drug Administration (USFDA).

Marksans Pharma stock zooms 16% to hit record high on strong Q1 results

The US & North America Formulation biz reported growth of 29.8% YoY in Q1FY25, on account of incremental revenue from new product launches, and increase in the share of existing customers.

Here's why Abbott India stock price surged 5% on August 8; details here

The uptick in the pharma company's stock price came after it posted a healthy set of numbers in the June quarter of financial year 2025 (Q1FY25).

USFDA issues 3 observations to Gland Pharma Hyderabad Unit, stock down 6%

The inspection at the Hyderabad facility took place between July 25, 2024 and August 02, 2024.

This Mukul Agrawal-owned stock crossed Rs 10,000-mark; up 725% in 2 years

Neuland Laboratories hit a new high of Rs 11,093.15, as the stock rallied 18% on the BSE in Friday's intra-day trade on the back of robust earnings for June 2024 quarter.

Pharma shares rally; Suven, Granules, Ajanta, Jubilant surge over 5%

Q1 earnings cheer: Lupin, Zydus Lifesciences, Glenmark Pharmaceuticals, Aurobindo Pharma, Torrent Pharmaceuticals and Sun Pharmaceutical were up between 2 per cent and 3 per cent.